Thyroglobulin (Tg) is a cost-effective and essential biomarker for monitoring differentiated thyroid cancer (DTC) follow-up, especially for low- and intermediate-risk patients with excellent treatment response [11], as per thyroid cancer guidelines [12]. This evidence concerns the gene TG and differentiated thyroid carcinoma.